Chemoprevention in Prostate Cancer: Current Perspective and Future Directions | Zendy

J. Ricardo Rivero | Zendy; Ian M. Thompson | Zendy; Michael A. Liss | Zendy; Dharam Kaushik | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Chemoprevention in Prostate Cancer: Current Perspective and Future Directions

Author(s) -

J. Ricardo Rivero,

Ian M. Thompson,

Michael A. Liss,

Dharam Kaushik

Publication year - 2018

Publication title -

cold spring harbor perspectives in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.853

H-Index - 105

eISSN - 2472-5412

pISSN - 2157-1422

DOI - 10.1101/cshperspect.a030494

Subject(s) - prostate cancer , medicine , prostate , disease , oncology , cancer , cancer research

Chemoprevention of prostate cancer aims to reduce the mortality as well as the public burden of overdetection, which increases anxiety, cost, and morbidity related to the disease. The role of 5-α-reductase inhibitors has been well investigated and shown to decrease the risk of prostate cancer. No current evidence exists to encourage the use of nutrients or vitamins as chemopreventive agents. The modulation of inflammation is one of the most promising targets for chemoprevention of prostate cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research